Globus Medical (GMED) said Wednesday it expects Q4 sales of about $657 million, up from $616.5 million a year earlier.
Analysts polled by FactSet expect $635.5 million.
The company said 2024 sales are expected to be about $2.52 billion.
Analysts surveyed by FactSet expect $2.5 billion.
Globus expects 2025 revenue of $2.66 billion to $2.69 billion and diluted non-GAAP earnings of $3.40 to $3.50 a share.
Analysts polled by FactSet expect revenue of $2.66 billion and EPS of $3.42.
Globus shares rose 2.8% in recent after-hours trading.
Price: 89.00, Change: +2.45, Percent Change: +2.83
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.